Total
0
Shares
Cann Group (ASX:CAN) - CEO, Peter Crock - The Market Herald
CEO, Peter Crock
Source: Cannabis Club Australia
  • Medical cannabis company Cann Group (CAN) has announced that investor Aurora Cannabis has dropped its stake in the company
  • Aurora sold its 11.84 per cent shareholding in Cann via off-market trades to a small number of buyers
  • Aurora said its plan to sell is consistent with its current strategic priorities
  • Nevertheless, Cann has reassured shareholders that Aurora's decision will not impact its business plans
  • On the market today, Cann is down 7.14 per cent, trading for 39 cents per share

Medical cannabis company Cann Group (CAN) has announced that investor Aurora Cannabis has dropped its stake in the company.

On Friday, Aurora sold its 11.84 per cent shareholding in Cann via off-market trades to a small number of buyers.

Aurora said its plan to sell is consistent with its current strategic priorities.

Nevertheless, Cann has reassured shareholders that Aurora's decision will not impact its business plans.

Currently, the company is "developing a growing and diversified supply base with business to business (B2B) customers in Australia and overseas and proceeding with plans to expand its manufacturing capacity."

In August, the company's 2020 financial year results came out. Cann's full-year revenue slipped 56 per cent to $1.86 million compared to the previous financial year.

With the Mildura facility expansion, Cann is expecting around $15 million in revenue for the 2021 financial year.

On the market today, Cann is down 7.14 per cent, trading for 39 cents per share at 12:31pm AEDT.


Subscribe


CAN by the numbers
More From The Market Herald
AnteoTech (ASX:ADO) - CEO, Derek Thomson - The Market Herald

" AnteoTech’s (ASX:ADO) rapid COVID-19 test approved in study

AnteoTech’s (ADO) COVID-19 antigen rapid test has been independently validated by Spanish lateral flow developer and manufacturer, Operon.
Global Health (ASX:GLH) - CEO, Mathew Cherian - The Market Herald

" Global Health (ASX:GLH) offers telehealth platform for free during COVID-19

Global Health (GLH) will offer its telehealth platform to the healthcare industry for free during the COVID-19 pandemic.
Zelda Therapeutics completes U.S. merger for perfect match

" Zelda Therapeutics completes U.S. merger for perfect match

Australian-listed Zelda Therapeutics (ZLD) has completed a merger with American company Ilera Therapeutics.
PainChek (ASX:PCK) - CEO, Philip Daffas - The Market Herald

" PainChek (ASX:PCK) expands to Canada market on new AlayaCare deal

PainChek (PCK) has extended its partnership agreement with AlayaCare which opens the opportunity for PainChek to enter the Canadian home care market.